This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Multiple myeloma/hypercalcemia
Arthritis Research & Therapy 2007, 9(Suppl 1):S4 doi:10.1186/ar2168
Accesses
- Last 30 days: 111 accesses
- Last 365 days: 1431 accesses
- All time: 6838 accesses

